182 related articles for article (PubMed ID: 22959624)
1. The CDK9 tail determines the reaction pathway of positive transcription elongation factor b.
Baumli S; Hole AJ; Wang LZ; Noble ME; Endicott JA
Structure; 2012 Oct; 20(10):1788-95. PubMed ID: 22959624
[TBL] [Abstract][Full Text] [Related]
2. The CDK9/cyclin T1 subunits of P-TEFb in mouse oocytes and preimplantation embryos: a possible role in embryonic genome activation.
Oqani RK; Kim HR; Diao YF; Park CS; Jin DI
BMC Dev Biol; 2011 Jun; 11():33. PubMed ID: 21639898
[TBL] [Abstract][Full Text] [Related]
3. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.
Dow EC; Liu H; Rice AP
J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073
[TBL] [Abstract][Full Text] [Related]
4. Development of temperature-sensitive mutants of the Drosophila melanogaster P-TEFb (Cyclin T/CDK9) heterodimer using yeast two-hybrid screening.
Kim S; Min IM; Ren S; Spector A; Jin MM; Lis JT
Biochem Biophys Res Commun; 2013 Apr; 433(2):243-8. PubMed ID: 23500466
[TBL] [Abstract][Full Text] [Related]
5. The emerging picture of CDK9/P-TEFb: more than 20 years of advances since PITALRE.
Paparidis NF; Durvale MC; Canduri F
Mol Biosyst; 2017 Jan; 13(2):246-276. PubMed ID: 27833949
[TBL] [Abstract][Full Text] [Related]
6. Halogen bonds form the basis for selective P-TEFb inhibition by DRB.
Baumli S; Endicott JA; Johnson LN
Chem Biol; 2010 Sep; 17(9):931-6. PubMed ID: 20851342
[TBL] [Abstract][Full Text] [Related]
7. Regulation of P-TEFb elongation complex activity by CDK9 acetylation.
Fu J; Yoon HG; Qin J; Wong J
Mol Cell Biol; 2007 Jul; 27(13):4641-51. PubMed ID: 17452463
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of HIV-1 Tat complexed with human P-TEFb.
Tahirov TH; Babayeva ND; Varzavand K; Cooper JJ; Sedore SC; Price DH
Nature; 2010 Jun; 465(7299):747-51. PubMed ID: 20535204
[TBL] [Abstract][Full Text] [Related]
9. Separate domains of fission yeast Cdk9 (P-TEFb) are required for capping enzyme recruitment and primed (Ser7-phosphorylated) Rpb1 carboxyl-terminal domain substrate recognition.
St Amour CV; Sansó M; Bösken CA; Lee KM; Larochelle S; Zhang C; Shokat KM; Geyer M; Fisher RP
Mol Cell Biol; 2012 Jul; 32(13):2372-83. PubMed ID: 22508988
[TBL] [Abstract][Full Text] [Related]
10. The CDK9 C-helix exhibits conformational plasticity that may explain the selectivity of CAN508.
Baumli S; Hole AJ; Noble ME; Endicott JA
ACS Chem Biol; 2012 May; 7(5):811-6. PubMed ID: 22292676
[TBL] [Abstract][Full Text] [Related]
11. Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription.
Sabò A; Lusic M; Cereseto A; Giacca M
Mol Cell Biol; 2008 Apr; 28(7):2201-12. PubMed ID: 18250157
[TBL] [Abstract][Full Text] [Related]
12. P-TEFb Kinase Activity Is Essential for Global Transcription, Resumption of Meiosis and Embryonic Genome Activation in Pig.
Oqani RK; Lin T; Lee JE; Choi KM; Shin HY; Jin DI
PLoS One; 2016; 11(3):e0152254. PubMed ID: 27011207
[TBL] [Abstract][Full Text] [Related]
13. AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation.
Lu H; Li Z; Xue Y; Schulze-Gahmen U; Johnson JR; Krogan NJ; Alber T; Zhou Q
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E15-24. PubMed ID: 24367103
[TBL] [Abstract][Full Text] [Related]
14. The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.
Baumli S; Lolli G; Lowe ED; Troiani S; Rusconi L; Bullock AN; Debreczeni JE; Knapp S; Johnson LN
EMBO J; 2008 Jul; 27(13):1907-18. PubMed ID: 18566585
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis.
Iankova I; Petersen RK; Annicotte JS; Chavey C; Hansen JB; Kratchmarova I; Sarruf D; Benkirane M; Kristiansen K; Fajas L
Mol Endocrinol; 2006 Jul; 20(7):1494-505. PubMed ID: 16484339
[TBL] [Abstract][Full Text] [Related]
16. Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II.
Lu H; Yu D; Hansen AS; Ganguly S; Liu R; Heckert A; Darzacq X; Zhou Q
Nature; 2018 Jun; 558(7709):318-323. PubMed ID: 29849146
[TBL] [Abstract][Full Text] [Related]
17. Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.
Ramanathan Y; Reza SM; Young TM; Mathews MB; Pe'ery T
J Virol; 1999 Jul; 73(7):5448-58. PubMed ID: 10364292
[TBL] [Abstract][Full Text] [Related]
18. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological targeting of CDK9 in cardiac hypertrophy.
Krystof V; Chamrád I; Jorda R; Kohoutek J
Med Res Rev; 2010 Jul; 30(4):646-66. PubMed ID: 19757441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]